Chitosan conjugated-ordered mesoporous silica: a biocompatible dissolution enhancer for promoting the antidiabetic effect of a poorly water-soluble drug of repaglinide

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Journal of Nanostructure in Chemistry

• Publication date

  2022-09-20

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s40097-022-00515-z
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Polysorbate-coated mesoporous silica nanoparticles as an efficient carrier for improved rivastigmine brain delivery.

  2022cited by this paper
• Characterization of Drugs with Good Glass Formers in Loaded-Mesoporous Silica and Its Theoretical Value Relevance with Mesopores Surface and Pore-Filling Capacity

  2022cited by this paper
• Calcium-based nanomaterials and their interrelation with chitosan: optimization for pCRISPR delivery

  2021cited by this paper
• Mesoporous Bioactive Glasses in Cancer Diagnosis and Therapy: Stimuli‐Responsive, Toxicity, Immunogenicity, and Clinical Translation

  2021cited by this paper
• The anti-diabetic effects of betanin in streptozotocin-induced diabetic rats through modulating AMPK/SIRT1/NF-κB signaling pathway

  2021cited by this paper
• Co-delivery of imidazolium Zn(II)salen and Origanum Syriacum essential oil by shrimp chitosan nanoparticles for antimicrobial applications.

  2021cited by this paper
• Chemotherapeutic and chemopreventive potentials of ρ-coumaric acid - Squid chitosan nanogel loaded with Syzygium aromaticum essential oil.

  2021cited by this paper
• Cu–curcumin/MCM-41 as an efficient catalyst for in situ conversion of carbazole to fuel oxygenates: a DOE approach

  2021cited by this paper
• Investigation of therapeutic effect of Curcumin α and β Glucoside anomers against Alzheimer's disease by the nose to brain drug delivery.

  2021cited by this paper
• Trends of nanotechnology in type 2 diabetes mellitus treatment

  2020cited by this paper
• Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.

  2020cited by this paper
• Antimicrobial effect of chitosan–silver–copper nanocomposite on Candida albicans

  2020cited by this paper
• Mitochondrial Glutathione: Recent Insights and Role in Disease

  2020cited by this paper
• Chitosan nano-vehicles as biocompatible delivering tools for a new Ag(I)curcuminoid-Gboxin analog complex in cancer and inflammation therapy.

  2020cited by this paper
• Inhibitory activity of biofunctionalized silver-capped N-methylated water-soluble chitosan thiomer for microbial and biofilm infections.

  2020cited by this paper
• Mesoporous Silica Nanoparticles for Drug Delivery

  2019cited by this paper
• Enlarged Pore Size Chiral Mesoporous Silica Nanoparticles Loaded Poorly Water-Soluble Drug Perform Superior Delivery Effect

  2019cited by this paper
• Mesoporous Silica-Based Materials with Bactericidal Properties.

  2019cited by this paper
• The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines.

  2019cited by this paper
• Polyphosphonium-oligochitosans decorated with nanosilver as new prospective inhibitors for common human enteric viruses.

  2019cited by this paper
• Water Soluble Chitosan Derivatives and their Biological Activities: A Review

  2019cited by this paper
• Impact of pharmacological agents on mitochondrial function: a growing opportunity?

  2019cited by this paper
• Nanoparticulate-based drug delivery systems for small molecule anti-diabetic drugs: An emerging paradigm for effective therapy.

  2018cited by this paper
• Phospholipid complex enriched micelles: A novel drug delivery approach for promoting the antidiabetic effect of repaglinide

  2017cited by this paper
• Anticancer Activity of Tamoxifen Loaded Tyrosine Decorated Biocompatible Fe3O4 Magnetic Nanoparticles Against Breast Cancer Cell Lines

  2017cited by this paper
• Chitosan Combined with ZnO, TiO2 and Ag Nanoparticles for Antimicrobial Wound Healing Applications: A Mini Review of the Research Trends

  2017cited by this paper
• Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles.

  2017cited by this paper
• Magnetic nanogels as dual triggered anticancer drug delivery: Toxicity evaluation on isolated rat liver mitochondria.

  2017cited by this paper
• Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.

  2017influential reference
• Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers

  2016cited by this paper
• Mesoporous silica formulation strategies for drug dissolution enhancement: a review

  2016cited by this paper
• Preparation and in vitro/in vivo evaluation of resveratrol-loaded carboxymethyl chitosan nanoparticles

  2016cited by this paper
• A dual-delivery system of pH-responsive chitosan-functionalized mesoporous silica nanoparticles bearing BMP-2 and dexamethasone for enhanced bone regeneration.

  2015cited by this paper
• Triboelectrification and dissolution property enhancements of solid dispersions.

  2015cited by this paper
• Crocin prevention of anemia-induced changes in structural and functional parameters of mice testes

  2015influential reference
• Biodistribution, excretion, and toxicity of mesoporous silica nanoparticles after oral administration depend on their shape.

  2015cited by this paper
• Synthesis of SBA-15/polyaniline mesoporous composite for removal of resorcinol from aqueous solution

  2014cited by this paper
• Chitosan-nanosilica hybrid materials: Preparation and properties

  2014cited by this paper
• Preparation, characterization, and adsorption evaluation of chitosan-functionalized mesoporous composites

  2014cited by this paper
• The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol

  2014cited by this paper
• Toxicity of Copper on Isolated Liver Mitochondria: Impairment at Complexes I, II, and IV Leads to Increased ROS Production

  2014influential reference
• Multifunctional Mesoporous Silica Nanoparticles as a Universal Platform for Drug Delivery

  2014cited by this paper
• Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.

  2014cited by this paper
• Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement.

  2013cited by this paper
• Mesoporous systems for poorly soluble drugs.

  2013cited by this paper
• Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica

  2013cited by this paper
• Mesoporous silica based macromolecules for dissolution enhancement of Irbesartan drug using pre-adjusted pH method

  2013cited by this paper
• Differential effects of complex II on mitochondrial ROS production and their relation to cardioprotective pre- and postconditioning.

  2013cited by this paper
• Coamorphous repaglinide-saccharin with enhanced dissolution.

  2013cited by this paper
• Inclusion of fenofibrate in a series of mesoporous silicas using microwave irradiation.

  2013cited by this paper
• Mesoporous silica nanoparticles in biomedical applications.

  2012cited by this paper
• A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles

  2012cited by this paper
• Surface functionalization of SBA-15 particles for amoxicillin delivery

  2012cited by this paper
• Nateglinide

  2012cited by this paper
• The stability and activity of respiratory Complex II is cardiolipin-dependent.

  2012cited by this paper
• Preparation, characterization and in vivo evaluation of antihyperglycemic activity of microwave generated repaglinide solid dispersion.

  2012cited by this paper
• Inclusion of the poorly water-soluble drug simvastatin in mesocellular foam nanoparticles: drug loading and release properties.

  2011cited by this paper
• Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.

  2011cited by this paper
• Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy.

  2011influential reference
• Recent Advances in Drug Delivery Systems

  2011cited by this paper
• Preparation, Characterization and in Vitro Evaluation of Repaglinide Binary Solid Dispersions with Hydrophilic Polymers

  2011cited by this paper
• Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.

  2011cited by this paper
• Mesoporous silica Nanoparticles as Drug Delivery System

  2011cited by this paper
• Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size.

  2011cited by this paper
• The cytotoxic mechanism of malondialdehyde and protective effect of carnosine via protein cross-linking/mitochondrial dysfunction/reactive oxygen species/MAPK pathway in neurons.

  2011cited by this paper
• Stabilized amorphous state of ibuprofen by co-spray drying with mesoporous SBA-15 to enhance dissolution properties.

  2010cited by this paper
• Synthesis, characterization, and in vitro pH-controllable drug release from mesoporous silica spheres with switchable gates.

  2010cited by this paper
• In vitro characterization and invivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles.

  2010cited by this paper
• PHASE SOLUBILITY STUDIES OF THE INCLUSION COMPLEXES OF REPAGLINIDE WITH β-CYCLODEXTRIN AND β-CYCLODEXTRIN DERIVATIVES

  2010cited by this paper
• Kinetic modeling on drug release from controlled drug delivery systems.

  2010cited by this paper
• DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles

  2010cited by this paper
• Protein Carbonylation

  2010cited by this paper
• Inclusion of telmisartan in mesocellular foam nanoparticles: drug loading and release property.

  2010cited by this paper
• Repaglinide‐loaded long‐circulating biodegradable nanoparticles: Rational approach for the management of type 2 diabetes mellitus

  2009cited by this paper
• Magnetic SBA-15/poly(N-isopropylacrylamide) composite: Preparation, characterization and temperature-responsive drug release property

  2009cited by this paper
• Membrane of hybrid chitosan-silica xerogel for guided bone regeneration.

  2009cited by this paper
• Micellar Solubilization of Some Poorly Soluble Antidiabetic Drugs: A Technical Note

  2008cited by this paper
• Recrystallization of Nifedipine and Felodipine from Amorphous Molecular Level Solid Dispersions Containing Poly(vinylpyrrolidone) and Sorbed Water

  2008cited by this paper
• Synthesis and Characterization of Positive‐Charge Functionalized Mesoporous Silica Nanoparticles for Oral Drug Delivery of an Anti‐Inflammatory Drug

  2008cited by this paper
• Rapidly dissolving repaglinide powders produced by the ultra-rapid freezing process

  2007cited by this paper
• Dissolution Rates and Supersaturation Behavior of Amorphous Repaglinide Particles Produced by Controlled Precipitation

  2007cited by this paper
• Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials.

  2007influential reference
• On the controllable soft-templating approach to mesoporous silicates.

  2007cited by this paper
• Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.

  2006influential reference
• Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles.

  2006influential reference
• Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization.

  2005cited by this paper
• Morphological Control of Rod- and Fiberlike SBA-15 Type Mesoporous Silica Using Water-Soluble Sodium Silicate

  2004influential reference
• Influence of pore size of MCM-41 matrices on drug delivery rate

  2004influential reference
• Morphological control of highly ordered mesoporous carbon

  2003cited by this paper
• Solid Dispersions of Diflunisal–PVP: Polymorphic and Amorphous States of the Drug

  2002cited by this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Repaglinide

  2002cited by this paper
• Modeling and comparison of dissolution profiles.

  2001influential reference
• What is the True Solubility Advantage for Amorphous Pharmaceuticals?

  2000cited by this paper
• Nateglinide

  2000cited by this paper
• Nonionic Triblock and Star Diblock Copolymer and Oligomeric Surfactant Syntheses of Highly Ordered, Hydrothermally Stable, Mesoporous Silica Structures

  1998influential reference
• The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay.

  1996cited by this paper
• In vitro/in vivo correlation of dissolution using moments of dissolution and transit times

  1986cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976influential reference
• The concept of dissolution efficiency

  1975cited by this paper
• A new look at the statistical model identification

  1974cited by this paper

• Drug delivery systems based on polysaccharides and inorganic nanoparticles: A comprehensive review on their therapeutic applications and recent advances

  2026cites this paper
• Nanoengineered Silica-Based Biomaterials for Regenerative Medicine

  2024cites this paper
• Multifractal Analysis and Experimental Evaluation of MCM-48 Mesoporous Silica as a Drug Delivery System for Metformin Hydrochloride

  2024cites this paper
• Recent advances in modifications, biotechnology, and biomedical applications of chitosan-based materials: A review.

  2024cites this paper